. Author manuscript; available in PMC: 2014 Nov 1.

Published in final edited form as: Br J Haematol. 2013 Sep 6;163(3):10.1111/bjh.12542. doi: 10.1111/bjh.12542

Table II.

Patient Characteristics

		Total

N		76

Group, n (%)	Group B	40 (53%)
Group, n (%)	Group C	36 (47%)

Gender, n (%)	Female	15 (20%)
Gender, n (%)	Male	61 (80%)

Age (years)	Mean, SD (range)	10,1, 5.2 (1.1–23.1)

Age (years), n (%)	< 4 years	9 (12%)
	4–15 years	51 (67%)
	> 15 years	16 (21%)

Pathological diagnosis, n (%)	Burkitt lymphoma	59 (78%)
	DLBCL	11 (14%)
	PMBL	2 (3%)
	NOS	4 (6%)

St. Jude Stage, n (%)	III	36 (47%)
St. Jude Stage, n (%)	IV	40 (53%)

LDH at reduction phase, n (%)	<2X ULN	28 (38%)
LDH at reduction phase, n (%)	≥2X ULN	45 (62%)

SD, standard deviation; DLBCL, diffuse large B-cell lymphoma; PMBL, primary mediastinal B-cell lymphoma; NOS, not otherwise specified; LDH, lactate dehydrogenase; UNL, upper limit of normal.